Institutional members access full text with Ovid®

Share this article on:

A selected review of the recent advances in craniomaxillofacial bone tissue engineering

Baskin, Jonathan Z.a,b; Eppell, Steven J.a

Current Opinion in Otolaryngology & Head and Neck Surgery: August 2013 - Volume 21 - Issue 4 - p 389–395
doi: 10.1097/MOO.0b013e328363203c
MAXILLOFACIAL SURGERY: Edited by Sherard A. Tatum

Purpose of review Craniofacial surgeons must continually make decisions about how to best reconstruct the craniomaxillofacial skeleton (CFS). A high priority has been placed on the search for bone substitute materials (BSMs) that are both mechanically and biologically optimized for these reconstructions. This review is intended to present the complexity of this undertaking to physicians and scientists by reviewing the technological advances published in the last 2 years.

Recent findings Advances in bone tissue engineering took place in the areas of scaffolds, bioactive factors (e.g. growth factors, cytokines, and pharmaceuticals), and cellular components. Recent literature highlighted the complex interplay between these elements. Researchers also made great strides in merging high-resolution imaging with computer-aided tissue engineering.

Summary Developing BSMs that fulfill the many needs in the CFS is difficult and there are multiple barriers to clinical translation. However, based on the progress in the last 2 years in the individual elements of BSM development as well as integration of those elements into implantable constructs, it appears that a product with specific CFS applications is on the horizon.

aDepartments of Otolaryngology – Head & Neck Surgery and Biomedical Engineering, Case Western Reserve University, University Hospitals Case Medical Center

bLouis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA

Correspondence to Jonathan Z. Baskin, MD, LSCVAMC, Department of Surgery, 112W, 10701 East Boulevard, Cleveland, OH 44106, USA. Tel: +1 216 791 3800 ext. 5632; fax: +1 216 421 3038; e-mail:

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins